LBP1

• UNSPSC Description:

  LBP1 is an orally active and low brain penetrant CB1 receptor agonist. LBP1 exhibits significant anti-allodynic and anti-hyperalgesic effects in rodent models of neuropathic pain[1].

• Target Antigen:

  Cannabinoid Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/lbp1.html

• Smiles:

  O=C(N)CN1CCN(CC2=NC(C3=CN(CC4CCOCC4)C5=C3C=CC=C5Cl)=NO2)CC1

• Molecular Weight:

  472.97

• References & Citations:

  [1]Adam J M, et al. Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain[J]. Bioorganic & medicinal chemistry letters, 2012, 22(8): 2932-2937.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1050478-18-6